Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
A research team has investigated structural changes in kidneys of patients with hypertension and type 2 diabetes. The results show that high blood pressure can lead to abnormalities in the podocytes, ...
Once-daily aprocitentan (Tryvio) is the first and only FDA-approved endothelin receptor antagonist for treating high blood pressure that remains uncontrolled despite other antihypertensive treatments.
Nearly half of Americans have hypertension, also known as high blood pressure. More than 119 million US adults have high blood pressure. Groundbreaking research reveals hypertension damages brain ...
High blood pressure (hypertension) and diabetes are both aspects of metabolic syndrome and often occur together. Possible reasons for this may be that they have similar risk factors, or that high ...
High blood pressure, or hypertension, can’t be permanently cured, but it can be effectively managed through ongoing lifestyle changes and, often, medication. Successfully managing hypertension ...
Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results